BiliaryTractCancer near Bayonne, NJ

Biography: Dr. Ravi P. Kiran is the co-director of the Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy at NewYork-Presbyerian/Columbia University Irving Medical Center. Prior to that, he served as chief and program director of the Division of Colorectal Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center for over a decade. He is also the Director of the Center for Innovation and Outcomes Research in the Department of Surgery. Dr. Kiran, a renowned surgeon-scientist with expertise in inflammatory bowel disease, colorectal cancer, and other complicated colorectal conditions, joined NewYork-Presbyterian/Columbia from the Cleveland Clinic, where he was staff surgeon and head of the research section in the Department of Colorectal Surgery and director of its Rupert B. Turnbull Jr. School of Enterostomal Therapy. Dr. Kiran brings a wealth of experience in laparoscopic and open colorectal surgery, anorectal procedures and reoperative abdominal and pelvic surgery. With expertise in inflammatory bowel disease (IBD) like complex Crohn's disease and ulcerative colitis, he specializes in bowel conservation as well as avoiding an ostomy (external bag) for these conditions when others may be unable. Having trained with Dr Victor Fazio at the Cleveland Clinic, he is an expert at pouch procedures. In addition to J and S pouch creation, he has experience in the repair, revision and redo of these pouches when pouch failure occurs. In addition to IBD, he is also expert in the surgical management of primary and recurrent colon and rectal cancer, diverticulitis, enterocutaneous fistula, functional bowel problems including constipation, incontinence and pelvic floor disorders. He is one of only a few highly skilled surgeons world-wide to perform continent ileostomy reservoir procedures and other complex operations to avoid a permanent ostomy after rectal or colon resection. As a researcher, Dr. Kiran has specific interests in surgical outcomes and quality and in evidence-based strategies for inflammatory bowel disease and other conditions. With a joint appointment at Columbia University Vagelos College of Physicians and Surgeons and at Columbia's Mailman School of Public Health, Dr. Kiran facilitates research collaborations in epidemiology between the Department of Surgery and the Mailman School. Dr. Kiran received his medical degree from and completed surgical training at Osmania Medical College in Hyderabad, India, and received advanced training in colorectal surgery in the United Kingdom. He completed his general surgery residency at Yale-Saint Mary's Hospital and Bronx-Lebanon Hospital Center and fellowship training in colorectal surgery at the Cleveland Clinic. He is board certified in surgery and in colon and rectal surgery from the American College of Surgeons (FACS) and the American Society of Colon and Rectal Surgeons (FASCRS) and is a fellow of the Royal Colleges of Surgeons of England and Glasgow. The author of more than 200 peer-reviewed publications, Dr. Kiran is also an editor and reviewer for numerous prominent journals and textbooks. As a student and physician, he has earned several distinctions, including the National Merit Scholarship and Gold Medals during his medical education and surgical training in India, Resident Researcher of the Year during surgical residency, Teacher of the Year in Colorectal Surgery at Cleveland Clinic in 2011, and the ASCRS Travelling Fellow Award in 2012. He has been voted to the list of Best Doctors in New York many times. Dr Kiran has a patient-centered approach to care and is available to see patients at the Main Campus, Midtown and New Jersey colorectal surgery office locations. Watch Video Profile

Care Philosophy: Terenig Terjanian, MD, is a hematologist and medical oncologist at Northwell Health, and an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Growing up in Lebanon, Dr. Terjanians early love for biology and chemistry set him on the path toward medicine. After attending St. Josephs University, he did a residency in pathology at American University of Beirut Medical Center, and one in internal medicine at Staten Island University Hospital. He then did fellowships in hematology and oncology at NYU Grossman School of Medicine and University of Texas MD Anderson Cancer Center. Although he initially specialized in pathology, Dr. Terjanian chose cancer care as a main focus after coming to the United States in 1981. ``The number one thing I want patients to know is that I'll listen to them,`` he says. ``I try to go over every aspect of their disease slowly, explain why we order the tests we do, and have them be completely aware of all the steps,`` he says, adding that he often gives patients his cell number, because he knows concerns can come up anytime. ``I think of what I would want as a patient, and it would be a doctor who really cares.`` Dr. Terjanian is deeply interested in clinical research. He has been the principal investigator on several protocols, including those of the National Surgical Adjuvant Breast and Bowel Project at Staten Island University Hospital, and has published multiple peer-reviewed papers and abstracts and presented at international meetings. He also runs the research committee for medical residents interested in hematology-oncology, and for fellows in that specialty. He's a member of the system-wide Institutional Review Board, a group that ensures clinical trials are done ethically and safely. In addition to participation in weekly tumor board meetings, and frequently providing lectures for interns and residents, Dr. Terjanian still enjoys the chemistry and biology that drew him to medicine from the start, especially since the science in oncology changes so rapidly which leads to improved patient outcomes. ``Every day, there is something new happening in cancer diagnosis and treatment, and it's exciting to see that progress,`` he says. ``Patients are living longer, they're experiencing better quality of life with targeted therapy or immunotherapy. Its immensely satisfying to see how far we've come.``

Biography: Dr. Onyinye Balogun is an Assistant Professor of Radiation Oncology at Weill Cornell Medicine specializing in the treatment of breast and gastrointestinalmalignancies.She is a graduate of Harvard University and Yale University School of Medicine. Dr. Balogun initiatedher residency training at the University of Chicago and completed her final year at New York University.She has conducted and published breast cancer research in novel therapeutics for triple negative breast cancer and brain metastases. She is also engaged in hepatocellular cancer research as well asglobal health activitieswith a focus on improving the delivery of radiation therapy in low and middle income countries.